Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DKL International was a medical technology company primarily known for developing and marketing the LifeGuard, a device claimed to detect human heartbeats from a distance. The company positioned the technology for use in search and rescue, law enforcement, and security applications. However, the device became the subject of significant controversy and legal action after independent testing by government agencies, including the FBI and Sandia National Laboratories, failed to verify its efficacy. The company's claims were ultimately widely discredited, leading to its cessation of major operations in the healthcare and security sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DKL International.